616. Vancomycin Is Frequently Administered to Hematopoietic Cell Transplant Recipients Without a Provider Documented Indication and Correlates with Microbiome Disruption and Adverse Events

BACKGROUND: The gut microbiome of hematopoietic cell transplant (HCT) recipients correlates with the risk of acute graft- vs.-host disease (aGVHD). IV vancomycin is the most commonly used nonprophylactic antibiotic in HCT recipients at our center. We evaluated indications for vancomycin use and impa...

Descripción completa

Detalles Bibliográficos
Autores principales: Golob, Jonathan, Stohs, Erica, Sweet, Ania, Pergam, Steven, Boeckh, Michael, Fredricks, David, Liu, Catherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255572/
http://dx.doi.org/10.1093/ofid/ofy210.623

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255572/
http://dx.doi.org/10.1093/ofid/ofy210.623

Ejemplares similares